Description:
A clinical candidate compound belonging to a family of piperidinone molecules.

Text:
However, the emergence of drug resistance 
due to mutations in p53 or MDM2 has underscored the need for developing nextgeneration 
inhibitors.17 Most p53MDM2 inhibitors bind to the Nterminal domain of MDM2, which 
consists of a core structured region, and an IDR referred to as a lid (Figure 1A).18 AM7209, 
a clinical candidate compound belonging to a family of piperidinone molecules, uniquely 
httpsdoi.org10.26434chemrxiv2024m15qmv2 ORCID httpsorcid.org0000000303601760 Content not peerreviewed by ChemRxiv. License CC BY 4.0
